2.240EUR-2.18%Mkt Cap: 30.71M $P/E: —1d ago
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the are…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap30.71M $
Enterprise Value22.79M $
Revenue (TTM)5.61M $
Gross Profit3.20M $
Net Income (TTM)-2.22M $
Revenue/Share0.4457 USD
Last Price2.240 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees20
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISINDE0006577109
Valuation
P/E (Trailing)—
P/E (Forward)-56.00
PEG—
EV/EBITDA-9.24
EV/Revenue4.06
P/S5.47
P/B0.76
EPS (TTM)-0.14
EPS (Forward)-0.04
52W Range
1.31085% of range2.400
52W High2.400 EUR
52W Low1.310 EUR
Profitability
Gross Margin63.38%
Oper. Margin-38.37%
EBITDA Margin-43.91%
Profit Margin-44.02%
ROE-5.36%
ROA-5.24%
Growth
Revenue Growth37.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF10.72M $
CapEx (TTM)437.61K $
FCF Margin—
FCF Yield—
Net Debt-7.92M $
Net Debt/EBITDA3.21
Balance Sheet
Debt/Equity—
Current Ratio31.90
Quick Ratio24.56
Book Value/Sh2.957 EUR
Cash/Share0.5780 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 16, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.400 EUR
Upside (mean)+96.4%
Target Range4.300 EUR – 4.500 EUR
€4.300+96.4% to mean€4.500
# Analysts2
Ownership
Shares Out.12.61M
Float—
Insiders2.00%
Institutions9.09%
Technical
SMA 501.855 (+20.8%)
SMA 2001.618 (+38.4%)
Beta0.52
S&P 52W Chg20.25%
Avg Vol (30d)22.61K
Avg Vol (10d)29.91K
Technical Indicators
RSI (14)64.0
MACD0.1031
MACD Signal0.1018
MACD Hist.+0.0013
BB Upper2.308 EUR
BB Middle2.105 EUR
BB Lower1.902 EUR
BB Width19.29%
ATR (14)0.1187 EUR
Vol Ratio (20d)0.28x